Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-25-086737

Options or other derivatives

  • Director acquired 38,513 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ryan David P. Director 2025-06-12 Grant or award · Stock Option (Right to Buy) +38,513 38,513 D: show line 1 in the form
Loading xslF345X05/ownership.xml…